Accessibility Statement

Accessibility Statement for Blippit Meds

Applies to: Blippit Meds v3, the clinical app and the admin console

Last updated: 1 August 2026

Get Logged In Ltd is the manufacturer of Blippit Meds. We want as many people as possible to be able to use it, and we test it rather than assume it works.

Conformance status

Blippit Meds is partially conformant with the Web Content Accessibility Guidelines (WCAG) 2.1 at Level AA. Partially conformant means some parts of the content do not fully conform to the standard.

No success criterion at Level A or Level AA is known to be unmet. Conformance is described as partial because a small number of criteria have not yet been formally assessed, and we do not claim conformance we have not verified.

How we have tested

Blippit Meds was last tested on 1 August 2026 by Get Logged In Ltd. Testing covered every screen of both the clinical app and the admin console, and combined automated auditing, a keyboard-only walkthrough of the clinical calculators, screen reader testing, zoom and text spacing testing, and a review of wording for reliance on colour or screen position.

The assessment has not been carried out by an independent third party, and we have not yet tested with people who have access needs. Both are planned.

Non-accessible content

We are aware of the following and are working on them.

  • Some navigation controls in the admin console cannot be operated by keyboard alone. This affects Trust administrators rather than clinical users, and it is our highest priority to fix.
  • A small number of success criteria have not yet been formally assessed, so we make no claim about them either way.

We are also arranging testing with additional screen readers and on tablet devices, and an independent audit.

Feedback and contact

If you encounter an accessibility barrier in Blippit Meds, or need information from the product in an alternative format, please tell us. We will respond as quickly as we can.

Get Logged In Ltd, trading as Blippit
Email: support@blippit.co.uk
Telephone: 01772 657100

If Blippit Meds is deployed at your Trust, you may also wish to raise the matter through your Trust's own accessibility or digital team, since your Trust has its own duties in respect of the systems it deploys.

Preparation of this statement

This statement was prepared on 1 August 2026 and reflects testing carried out between 30 July and 1 August 2026. It is reviewed whenever either application changes materially, and otherwise annually.

A full criterion-by-criterion assessment is held as a controlled document and is supplied to deploying NHS Trusts on request.

Blippit Meds v3 is software intended for use as a Class I medical device under the UK Medical Devices Regulations 2002 (as amended).

Help and documentation  |  Privacy policy